IP Verse

Silicone-Containing Acrylic Polymers For Transdermal Drug Delivery Compositions

Patent No. EP3179989 (titled "Silicone-Containing Acrylic Polymers For Transdermal Drug Delivery Compositions") was filed by Noven Pharmaceuticals on Jul 28, 2015. The application was issued on Jun 12, 2019.

Patent Summary

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
LTS LOHMANN THERAPIE SYSTEME	Mar 11, 2020	MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 28, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Sep 28, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Sep 23, 2021
Termination of the opposition proceedings with revocation of patent
Jun 18, 2021
Advice of delivery
Jun 14, 2021
(Electronic) Receipt
Jun 14, 2021
Advice of delivery
Jun 14, 2021
Decision of the Opposition Division and instruction
Jun 14, 2021
Decision revoking the European patent
Jun 14, 2021
Decision revoking the European patent
Jun 14, 2021
Grounds for the decision (Annex) - opposition
Jun 14, 2021
Internal form - Opposition/addressees
Jun 14, 2021
Letter accompanying subsequently filed items
Jun 14, 2021
Letter accompanying subsequently filed items
Jun 14, 2021
Means of redress
Jun 14, 2021
Transmittal of decision / summons - opposition
Jun 14, 2021
Transmittal of decision / summons - opposition
May 6, 2021
Notification concerning the date of oral proceedings
May 6, 2021
Notification concerning the date of oral proceedings
May 3, 2021
Brief communication - Opposition proceedings
Apr 22, 2021
(Electronic) Receipt
Apr 22, 2021
Letter accompanying subsequently filed items
Apr 22, 2021
Written submission in preparation to/during oral proceedings
Mar 11, 2021
Notification concerning the date of oral proceedings
Mar 11, 2021
Notification concerning the date of oral proceedings
Nov 6, 2020
(Electronic) Receipt
Nov 6, 2020
Advice of delivery
Nov 6, 2020
Letter accompanying subsequently filed items
Nov 5, 2020
Advice of delivery
Nov 2, 2020
Acknowledgement of a document
Nov 2, 2020
Acknowledgement of a document
Nov 2, 2020
Annex to the communication - opposition
Nov 2, 2020
Information concerning oral proceedings
Nov 2, 2020
Summons to attend oral proceedings
Nov 2, 2020
Summons to attend oral proceedings
Aug 27, 2020
Brief communication - Opposition proceedings
Aug 14, 2020
(Electronic) Receipt
Aug 14, 2020
Letter accompanying subsequently filed items
Aug 14, 2020
Reply of the patent proprietor to the notice(s) of opposition
Mar 26, 2020
Communication of a notice of opposition and request to file observations
Mar 26, 2020
Notice of further oppositions to opponent(s)
Mar 17, 2020
Communication of a notice of opposition - first information to patent proprietor
Mar 11, 2020
(Electronic) Receipt
Mar 11, 2020
Citation in opposition procedure - 001
Mar 11, 2020
Citation in opposition procedure - 002
Mar 11, 2020
Citation in opposition procedure - 003
Mar 11, 2020
Citation in opposition procedure - 004
Mar 11, 2020
Citation in opposition procedure - 005
Mar 11, 2020
Consolidated list of cited opposition documents
Mar 11, 2020
Notice of opposition
Mar 11, 2020
Notice of opposition
Jul 9, 2019
Payment submission rejected
Jun 25, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
May 16, 2019
Decision to grant a European patent
May 2, 2019
(Electronic) Receipt
May 2, 2019
Filing of the translations of the claims
May 2, 2019
Letter accompanying subsequently filed items
Mar 12, 2019
Bibliographic data of the European patent application
Mar 12, 2019
Communication about intention to grant a European patent
Mar 12, 2019
Intention to grant (signatures)
Mar 12, 2019
Text intended for grant (clean copy)
Mar 12, 2019
Text intended for grant (version for approval)
Feb 13, 2019
(Electronic) Receipt
Feb 13, 2019
Amended description with annotations
Feb 13, 2019
Description
Feb 13, 2019
French translation of claims
Feb 13, 2019
German translation of the claims
Feb 13, 2019
Letter accompanying subsequently filed items
Feb 13, 2019
Request for correction/amendment of the text proposed for grant sent from 01.04.2012
Oct 17, 2018
Bibliographic data of the European patent application
Oct 17, 2018
Communication about intention to grant a European patent
Oct 17, 2018
Intention to grant (signatures)
Oct 17, 2018
Text intended for grant (clean copy)
Oct 17, 2018
Text intended for grant (version for approval)
Sep 12, 2018
Examination started
Sep 14, 2017
(Electronic) Receipt
Sep 14, 2017
Amended claims filed after receipt of (European) search report
Sep 14, 2017
Amended claims with annotations
Sep 14, 2017
Amended description filed after receipt of (European) search report
Sep 14, 2017
Amendments received before examination
Sep 14, 2017
Description
Sep 14, 2017
Letter accompanying subsequently filed items
May 24, 2017
Notification on forthcoming publication of bibliographic data
Mar 27, 2017
(Electronic) Receipt
Mar 27, 2017
Authorisation
Mar 27, 2017
Letter accompanying subsequently filed items
Mar 27, 2017
Matter concerning the application
Mar 7, 2017
Communication regarding comments on written opinion/amendment of application/payment of claims fee
Mar 6, 2017
Invitation to file authorisation
Mar 3, 2017
Communication to designated inventor
Mar 3, 2017
Communication to designated inventor
Mar 3, 2017
Communication to designated inventor
Mar 3, 2017
Communication to designated inventor
Feb 20, 2017
(Electronic) Receipt
Feb 20, 2017
Amended claims filed after receipt of (European) search report
Feb 20, 2017
Amended claims with annotations
Feb 20, 2017
Amendments received before examination
Feb 20, 2017
Request for entry into the European phase
Feb 7, 2017
Annexes to the international preliminary examination report
Feb 7, 2017
Copy of the international preliminary examination report
Dec 9, 2016
Information on entry into European phase
Oct 5, 2016
Annex to International preliminary examination report
Oct 5, 2016
International preliminary examination report
Oct 5, 2016
International preliminary examination report - free text sheet
Oct 5, 2016
International preliminary examination report - points I-VIII
Oct 5, 2016
Transmittal of International Preliminary Examination Report
Jul 1, 2016
Written opinion
Jul 1, 2016
Written opinion - free text sheet
Jul 1, 2016
Written opinion - points I-VIII
Jun 28, 2016
Notification of election of EPO
Jun 16, 2016
Amendments of documents (Article 19 PCT) (without attachments)
Jun 13, 2016
Notification of receipt of demand
Jun 6, 2016
Document concerning fees and payments
Jun 6, 2016
Notification of transmittal of demand to the competent IPEA
Jun 6, 2016
PCT(IPEA): Amended sheet - claims
May 27, 2016
PCT demand form
May 27, 2016
Payment of fees and costs
Feb 22, 2016
Priority document (electronically transmitted)
Feb 4, 2016
Copy of the international search report
Feb 4, 2016
Published international application - A1
Oct 23, 2015
ISR: cited documents
Oct 22, 2015
Written opinion of the ISA, boxes No. I to VIII
Oct 22, 2015
Written opinion of the ISA, cover sheet
Oct 22, 2015
Written opinion of the ISA, supplemental box
Aug 20, 2015
Notification of receipt of Search copy
Aug 3, 2015
Abstract
Aug 3, 2015
Annex
Aug 3, 2015
Claims
Aug 3, 2015
Description
Aug 3, 2015
Drawings

EP3179989

NOVEN PHARMACEUTICALS

Application Number: EP15747711A
Filing Date: Jul 28, 2015
Status: Revoked; Sep 24, 2021
Publication Date: Jun 12, 2019
External Links: Slate, Register , Google Patents